SB-282241



SB-282241

O Cl Cl N H N N H O H

SMILES O=C(/C=C/c1ccc(Cl)c(Cl)c1)NCCCCCN1CCC(c2c[nH]c3ccc(O)cc23)CC1
InChIKey QBRLVMQBZIFWTB-WEVVVXLNSA-N

Chemical Properties

Hydrogen bond acceptors 3
Hydrogen bond donors 3
Rotatable bonds 9
Molecular weight (Da) 499.2

Database connections

Ligand site mutations CCR2


Bioactivities

SB-282241

O Cl Cl N H N N H O H

Drug properties

Molecular type Small molecule
Physiological/Surrogate Surrogate
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV

Database connections

Ligand site mutations CCR2


Compound is not listed as a drug.